Phosphoinositide 3-kinase inhibition in the treatment of hormone receptor-positive breast cancer.

Phosphoinositide 3-kinase inhibition in the treatment of hormone receptor-positive breast cancer. Clin Adv Hematol Oncol. 2019 Sep;17(9):486-489 Authors: Rugo HS PMID: 31549968 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research